GHK-Cu / KPV Mix is studied in dermatological and anti-aging research, e.g. in relation to skin and pigmentation models. Via its copper component, GHK-Cu supplies a cofactor for lysyl oxidase. Unlike full-length alpha-MSH, KPV does not bind melanocortin receptors; it is taken up via PepT1 and is associated with inhibition of the NF-kB pathway.
The blend is discussed as a research approach that combines GHK-Cu's structural/regenerative direction with KPV's anti-inflammatory direction. No study evidence specific to the combination exists to date.
Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.
Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.
The evidence base for skin and pigmentation peptides is largely based on preclinical and early clinical investigations.
References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.
We reply personally – via email or Telegram.